Brexpiprazole Gets Priority Review for Agitation With Alzheimer Dementia
The FDA has accepted for Priority Review the sNDA for brexpiprazole for the treatment of agitation associated with Alzheimer dementia.
Source: empr.com
📰 Priority Review News
Page 79 - Priority Review News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Priority Review. Real-time updates on events, politics, business and more.
FDA to Review 20-Valent Pneumococcal Conjugate Vaccine for Pediatric Use
The FDA has accepted for Priority Review the sBLA for the 20-valent pneumococcal conjugate vaccine for use in infants and children.
Source: empr.com
Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism
/PRNewswire/ -- VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, announced today that it has completed the...
Ascendis Pharma Us Food Drug Administration European Medicines Agency National Medical Products Administration China Trial Executive Director
Source: prnewswire.com
UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review
Biologic License Application (BLA) designated Priority Review by FDA and seeks approval for rozanolixizumab for the treatment of adults with generalized...
Source: prnewswire.com
FDA Grants Accelerated Approval for Alzheimer's Disease Treatment
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of...
United States Billy Dunn Eisai Rd Management Co Ltd Drug Administration Office Of Neuroscience Accelerated Approval
Source: prnewswire.com
Rozanolixizumab Gets Priority Review for Generalized Myasthenia Gravis
The FDA has accepted for Priority Review the BLA for rozanolixizumab for the treatment of adults with generalized myasthenia gravis.
Drug Administration Priority Review Biologics License Application Myasthenia Gravis Activities Daily Living Quantitative Myasthenia Gravis
Source: empr.com
FDA Grants Accelerated Approval for Alzheimer's Disease Treatment
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of...
United States Billy Dunn Eisai Rd Management Co Ltd Drug Administration Office Of Neuroscience Accelerated Approval
Source: prnewswire.com
Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
Source: prnewswire.com
Sedana Medical receives FDA Fast Track Designation in the United States
/PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track...
United States United Kingdom Great Britain Johan Spetz Certified Adviser Is Erik Penser Bank Drug Administration
Source: prnewswire.com
Bicycle Therapeutics plc: Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer
Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced
Source: finanznachrichten.de